Argent Biopharma Limited has released a press release.
Ethics Committee Approval Granted Phase III Clinical Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- SwissPharmaCan AG increases initial purchase order
- MGC Pharma first medicinal cannabis company to list on LSE
- MGC Pharma Investor Presentation
- December Quarterly Activity and Cashflow Report
- ArtemiC Phase II Clinical Trial Results
Later from Argent Biopharma
- Mxc completes first artemic order, march qtr record revenue
- Investor presentation
- Mgc pharma to acquire medical research company medicanl
- March quarterly activity and cashflow report
- Artemic submitted to health canada
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma